Description
Sculptra is a sophisticated injectable treatment composed of Poly-L-Lactic Acid (PLLA). Unlike traditional hyaluronic acid fillers that simply “fill” space, Sculptra works deep within the dermis to revitalize the skin’s natural regenerative process. It is the first and only FDA-approved PLLA collagen stimulator that gradually restores facial volume and improves skin structural integrity.
Clinical Indications & Target Areas
Sculptra is engineered for global facial rejuvenation and the correction of large-scale volume loss:
-
Hollow Cheeks & Temples: Restoring youthful fullness to sunken areas.
-
Deep Nasolabial Folds: Softening “smile lines” by strengthening the skin’s foundation.
-
Jawline Tightening: Enhancing definition by improving skin laxity.
-
Skin Quality: Overall improvement in skin thickness and texture.
-
Body Contouring: Often used off-label for hip dip correction and gluteal augmentation.
Technical Excellence & Mechanism of Action
-
Collagen Biostimulation: PLLA micro-particles act as a biological trigger, stimulating the body’s own fibroblasts to produce new Type I collagen.
-
Gradual Results: Results appear subtly and progressively over several months, avoiding the “over-filled” look of instant injections.
-
Biocompatible & Biodegradable: PLLA has been used in medical implants and dissolvable stitches for decades, ensuring a high safety profile.
-
Durability: Once the collagen framework is rebuilt, the aesthetic improvements can last up to 25 months or longer.
The Professional Advantage
-
Long-Term ROI: While it requires a series of treatments (typically 2 to 3 sessions), the longevity of Sculptra far exceeds that of standard HA fillers.
-
Structural Restoration: It treats the underlying cause of facial aging—collagen loss—rather than just the symptoms.
-
Discreet Enhancement: Ideal for patients seeking a natural transformation that “no one will notice, but everyone will see.”
Administration & Preparation
Professional Use Only: Sculptra requires a specific reconstitution process (dilution with sterile water for injection) and a precise waiting period before administration. Only practitioners trained in PLLA injection techniques should perform this treatment.
-
Vial Contents: 150mg of Poly-L-Lactic Acid in dry powder form.
-
Reconstitution: Must be prepared according to the manufacturer’s protocol (typically 5ml to 8ml of diluent).
-
Storage: Store at room temperature (20C to 25C).



Reviews
There are no reviews yet.